Hongliang Dong

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 22, 2022
De Novo mutation in Epidermal growth factor receptor (EGFR)-D761Y responding to third generation tyrosine kinase inhibitor Osimertinib: A case report.

Yingying Ding, Hongliang Dong, YongCheng Li

Pageof 1

Frequent Collaborators